A genetic link between type 2 diabetes and prostate cancer - Commentary

被引:72
作者
Frayling, T. M. [1 ]
Colhoun, H. [2 ]
Florez, J. C. [3 ,4 ]
机构
[1] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England
[2] Univ Dundee, Dundee, Scotland
[3] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA
关键词
epidemiology; genes; genome-wide association study; pleiotropy; prostate cancer; transcription factors; type; 2; diabetes;
D O I
10.1007/s00125-008-1114-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epidemiological studies suggest that men with type 2 diabetes are less likely than non-diabetic men to develop prostate cancer. The cause of this association is not known. Recent genetic studies have highlighted a potential genetic link between the two diseases. Two studies have identified a version (allele) of a variant in the HNF1B (also known as TCF2) gene that predisposes to type 2 diabetes, and one of them showed that the same allele protects men from prostate cancer. Other, separate, studies have identified different variants in the JAZF1 gene, one associated with type 2 diabetes, another associated with prostate cancer. These findings are unlikely to completely explain the epidemiological association between the two diseases but they provide new insight into a possible direct causal link, rather than one that is confounded or biased in some way.
引用
收藏
页码:1757 / 1760
页数:4
相关论文
共 29 条
  • [1] History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study
    Calton, Brook A.
    Chang, Shih Chen
    Wright, Margaret E.
    Kipnis, Victor
    Lawson, Karla
    Thompson, Frances E.
    Subar, Amy F.
    Mouw, Traci
    Campbell, David S.
    Hurwitz, Paul
    Hollenbeck, Albert
    Schatzkin, Arthur
    Leitzmann, Michael F.
    [J]. CANCER CAUSES & CONTROL, 2007, 18 (05) : 493 - 503
  • [2] Mutations in hepatocyte nuclear factor-1β and their related phenotypes
    Edghill, EL
    Bingham, C
    Ellard, S
    Hattersley, AT
    [J]. JOURNAL OF MEDICAL GENETICS, 2006, 43 (01) : 84 - 90
  • [3] Metformin and reduced risk of cancer in diabetic patients
    Evans, JMM
    Donnelly, LA
    Emslie-Smith, AM
    Alessi, DR
    Morris, AD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503): : 1304 - 1305
  • [4] Genome-wide association studies provide new insights into type 2 diabetes aetiology
    Frayling, Timothy M.
    [J]. NATURE REVIEWS GENETICS, 2007, 8 (09) : 657 - 662
  • [5] Diabetes mellitus and risk of prostate cancer (United States)
    Giovannucci, E
    Rimm, EB
    Stampfer, MJ
    Colditz, GA
    Willett, WC
    [J]. CANCER CAUSES & CONTROL, 1998, 9 (01) : 3 - 9
  • [6] Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial
    Gong, Zhihong
    Neuhouser, Marian L.
    Goodman, Phyllis J.
    Albanes, Demetrius
    Chi, Chen
    Hsing, Ann W.
    Lippman, Scott M.
    Platz, Elizabeth A.
    Pollak, Michael N.
    Thompson, Ian M.
    Kristal, Alan R.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1977 - 1983
  • [7] The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas
    Govannucci, Edward
    Michaud, Dominique
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2208 - 2225
  • [8] Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
    Gregory, Simon G.
    Schmidt, Silke
    Seth, Puneet
    Oksenberg, Jorge R.
    Hart, John
    Prokop, Angela
    Caillier, Stacy J.
    Ban, Maria
    Goris, An
    Barcellos, Lisa F.
    Lincoln, Robin
    McCauley, Jacob L.
    Sawcer, Stephen J.
    Compston, D. A. S.
    Dubois, Benedicte
    Hauser, Stephen L.
    Garcia-Blanco, Mariano A.
    Pericak-Vance, Margaret A.
    Haines, Jonathan L.
    [J]. NATURE GENETICS, 2007, 39 (09) : 1083 - 1091
  • [9] Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
    Gudmundsson, Julius
    Sulem, Patrick
    Steinthorsdottir, Valgerdur
    Bergthorsson, Jon T.
    Thorleifsson, Gudmar
    Manolescu, Andrei
    Rafnar, Thorunn
    Gudbjartsson, Daniel
    Agnarsson, Bjarni A.
    Baker, Adam
    Sigurdsson, Asgeir
    Benediktsdottir, Kristrun R.
    Jakobsdottir, Margret
    Blondal, Thorarinn
    Stacey, Simon N.
    Helgason, Agnar
    Gunnarsdottir, Steinunn
    Olafsdottir, Adalheidur
    Kristinsson, Kari T.
    Birgisdottir, Birgitta
    Ghosh, Shyamali
    Thorlacius, Steinunn
    Magnusdottir, Dana
    Stefansdottir, Gerdur
    Kristjansson, Kristleifur
    Bagger, Yu
    Wilensky, Robert L.
    Reilly, Muredach P.
    Morris, Andrew D.
    Kimber, Charlotte H.
    Adeyemo, Adebowale
    Chen, Yuanxiu
    Zhou, Jie
    So, Wing-Yee
    Tong, Peter C. Y.
    Ng, Maggie C. Y.
    Hansen, Torben
    Andersen, Gitte
    Borch-Johnsen, Knut
    Jorgensen, Torben
    Tres, Alejandro
    Fuertes, Fernando
    Ruiz-Echarri, Manuel
    Asin, Laura
    Saez, Berta
    van Boven, Erica
    Klaver, Siem
    Swinkels, Dorine W.
    Aben, Katja K.
    Graif, Theresa
    [J]. NATURE GENETICS, 2007, 39 (08) : 977 - 983
  • [10] Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years
    Haheim, L. Lund
    Wisloff, T. F.
    Holme, I.
    Nafstad, P.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (08) : 769 - 774